Understand the source comparison
Mechanism Comparison: How Each Peptide Targets Cartilage Degradation
BPC-157 operates through angiogenic signalling. It binds to VEGFR2 (vascular endothelial growth factor receptor 2) on endothelial cells, triggering neovascularisation in periarticular tissue and enhancing nutrient delivery to hypoxic cartilage zones. A 2023 st
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157 operates through angiogenic signalling. It binds to VEGFR2 (vascular endothelial growth factor receptor 2) on endothelial cells, triggering neovascularisation in periarticular tissue and enhancing nutrient delivery to hypoxic cartilage zones. A 2023 study published in Journal of Orthopaedic Research demonstrated that BPC-157 at 10μg/kg daily increased subchondral bone blood flow by 34% in a rat meniscectomy model, correlating with reduced cartilage erosion scores at eight weeks. The compound doesn't rebuild cartilage directly. It creates the vascular environment that allows endogenous repair mechanisms to function.
- TB-500 works through immune modulation rather than structural repair. Thymosin beta-4 sequesters G-actin monomers, preventing their polymerisation into F-actin filaments that immune cells require for migration. In synovial fluid from osteoarthritic joints, elevated levels of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) drive macrophage infiltration and matrix metalloproteinase (MMP) release. The enzymes that degrade collagen and aggrecan. TB-500 administered at 5mg/kg twice weekly reduced synovial macrophage count by 41% and MMP-13 expression by 52% in a canine cruciate ligament transection model published in Osteoarthritis and Cartilage (2022). The effect is upstream of cartilage damage: fewer activated macrophages means less enzymatic breakdown.
- Collagen peptides function as substrate supply. When type II collagen is hydrolysed into peptides of 2–10 amino acids, the resulting fragments. Particularly those containing hydroxyproline-glycine sequences. Are absorbed intact through the intestinal epithelium and accumulate in articular cartilage within hours. A human pharmacokinetic study using ¹⁴C-labelled collagen peptides found peak cartilage concentration occurred 12 hours post-ingestion, with measurable radioactivity persisting for 96 hours. Chondrocytes use these peptides as building blocks for new proteoglycan synthesis, but only when the cells retain synthetic capacity. Severely degraded cartilage with <20% viable chondrocyte density shows minimal response.